about
Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studiesSex differences in nicotine substitution to a pentylenetetrazol discriminative stimulus during ethanol withdrawal in rats.Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal.The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments.Abuse liability profile of three substituted tryptamines.Transfer of contextual stimulus function via equivalence class development.The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice.Neuropharmacology of N,N-dimethyltryptamineΔ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and ratsAbuse liability of the dietary supplement dimethylamylamine.Discriminative and locomotor effects of five synthetic cathinones in rats and miceΔ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market.Comparative Behavioral Pharmacology of Three Pyrrolidine-Containing Synthetic Cathinone DerivativesDiscriminative stimulus effects of N,N-diisopropyltryptamineNicotine and methamphetamine share discriminative stimulus effectsEffects of ethanol on cocaine discrimination in rats.Ethanol withdrawal and hyperalgesia.Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats.Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys.Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodentsCarisoprodol tolerance and precipitated withdrawal.Effects of calcium channel blockers on pentylenetetrazol drug discrimination in rats.Effects of GABA(A) compounds on mCPP drug discrimination in rats.Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys.Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine.Ethanol substitutes for the discriminative stimulus effects of m-chlorophenylpiperazine."Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.Δ(9)-Tetrahydrocannabinol-like discriminative stimulus effects of five novel synthetic cannabinoids in rats.Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.Effects of ritanserin on ethanol withdrawal-induced anxiety in rats.Effects of NMDA antagonists on ethanol-withdrawal induced "anxiety" in the elevated plus maze.Antinociceptive effects of cocaine in rhesus monkeys.The effects of adenosine ligands R-PIA and CPT on ethanol withdrawal.Training and characterization of a quinine taste discrimination in rhesus monkeys.Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.Naloxonazine antagonism of levorphanol-induced antinociception and respiratory depression in rhesus monkeysPharmacological treatment of alcoholism
P50
Q24655305-930B5745-C5F6-422F-A548-301B02E61A0BQ31385295-2E6023C1-52A8-434B-B256-BE8CF2F32608Q33915689-E5D357A4-9298-4D08-B3F5-FBC547B36EA4Q34146895-6D5AE0B1-7B7E-43CF-AFA6-B1955C099C62Q34176654-7D01CE35-3134-4604-B0E0-416BDC4D7A5AQ34282337-B27C76F0-FFDA-4205-9E58-4ABB9B471ADFQ34427453-C93CCFAA-8DFD-4480-9214-46DF7C47AB5DQ34437634-DC17869B-40CA-4139-B6E1-8F5F7FC0D5EBQ34524116-3124DA9B-7936-43A7-8A2D-54BE88DBBDA5Q34675734-3503A1C8-1C35-4606-80B0-BCEB744AE0B7Q34749168-C49D53D2-83B6-458B-A7F5-414665E42C80Q35181582-A168358D-4A4D-4A38-9921-C9BEDAA0C3FAQ35836423-F86D3FE1-2193-4556-BC66-B5B701987096Q35897800-22D3ED0A-08BD-4F8C-827A-F64152EFDED2Q36625158-B6B869AA-6214-4FCC-93EB-C120CF914942Q36649143-17DA15CA-B69B-4653-88F8-1BBAE66561BAQ37425459-08F25571-1FB6-4E0A-B198-271267711D72Q37561332-72F11DE3-A2DC-4F54-B959-BBA3676C1C8AQ37622283-0B60AFD1-4437-4864-A3E9-31AE150BEB87Q38955985-89A8A9FF-3130-40FD-92AA-370456EF2E01Q39788585-BAE9E244-9EF7-4A72-B3E2-3E94CCE4C87AQ42274705-B06ACEC0-7288-42ED-998E-B2760B406DB1Q42395888-B6FC966E-0524-40DB-93D6-BA68B15DFE6EQ42631946-FB74A6F6-2DD7-4728-B393-A28C410F3735Q43660163-1D33E10C-F575-4552-B3CE-04F38BF1AC16Q44158863-59BF915A-8C31-4830-A356-AB2B8A620503Q44348030-6E7B63A6-48BF-4D45-B663-FC2D2AFFA799Q44348306-ED7FF60D-D24B-44CF-A615-1219D72F650CQ46779491-EEEBE026-3705-4C1C-B484-CE21257BACB4Q49602724-6C4C6B18-590D-46D0-9689-689C0E7F3F89Q50014079-BD4E0EC3-0A90-4C29-B7A1-2C8115060FAAQ50627353-287A7998-A7D3-465D-A72E-C5E088AD0D91Q51076480-3126214D-C8B1-4E1B-9C00-7DDD8E1204E0Q51084378-0786F0E1-AD10-45CE-AED6-926DFB3D321AQ51475757-BEDC2AC7-4F36-4E15-ADDD-EA0A1E462203Q52174509-1EDBEECA-0605-40BE-9094-FB70E4BC7F79Q52179261-4015689D-586C-4F10-BC58-32C7FDC47A49Q53087323-1D3E67AF-63BD-424D-A946-CC49A7A9D493Q71677755-33BB4A82-5AC6-4FF2-B0D6-C342776D4477Q77468736-27C2BEA0-C222-4501-9C32-1F5ED061583A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael B Gatch
@ast
Michael B Gatch
@en
Michael B Gatch
@es
Michael B Gatch
@nl
type
label
Michael B Gatch
@ast
Michael B Gatch
@en
Michael B Gatch
@es
Michael B Gatch
@nl
prefLabel
Michael B Gatch
@ast
Michael B Gatch
@en
Michael B Gatch
@es
Michael B Gatch
@nl
P106
P1153
7004611348
P31
P496
0000-0003-3474-211X